Presenter: Tyler Reimschisel, MD Preceptor: Harvey Singer, MD

Disclosures

October 07, 2002

Update on the Patient's Clinical Status

The patient was referred to an institution close to her home. That institution is currently studying the efficacy of TM and zinc vs trientine alone in a blinded trial. Approximately 3 months after starting therapy, her speech and swallowing have improved but are not normal. She has now developed a tremor and has also been diagnosed with depression. This relatively minor decline in neurologic status is common within the first months of therapy.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....